News New NICE rules could deny drugs to rare disease patients Patients could be denied treatments, says BIA
News Shire fined $350m for skin product bribes Settlement relates to investigation into Dermagraft sales.
News Intercept's Ocaliva approved in EU for liver disease Potential liver blockbuster gets EU licence.
News NICE rejects Shire pancreatic cancer drug Onivyde not eligible for Cancer Drugs Fund, says NICE.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
